Dergiler / Haseki Tıp Bülteni / 2021 / Cilt: 59 - Sayı: 4

Risk Factors and Seroprevalence of Syphilis Among Naive HIV Patients: A Cross-Sectional Study From a Tertiary Center

Sayfa
313–318
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Positive syphilis antibody rate was found to be statistically higher in patients with substance abuse (p<0.01), CD4+ T lymphocytecounts were under 200 cell/mm³ (p=0.018) and viral load above 100.000 copies/mL (p<0.01).Conclusion: Among HIV-infected patients, those with MSM and substance abuse constitute the group at highest risk of syphilis.Therefore, syphilis must be screened and treated, especially at HIV diagnosis and high-risk behaviors.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: Syphilis coinfection is common among human immune deficiency virus (HIV)/acquired immune deficiency syndrome (AIDS)diagnosed patients.
📊
Temel Bulgular & Veri:We aimed to investigate the rates of syphilis coinfection, social-demographical features, viral and immunologicalproperties among naive HIV/AIDS patients.Methods: Socio-demographical data, CD4+ T lymphocyte counts, HIV viral load, syphilis antibody results and physical examinations atthe time of diagnosis of naive HIV infected patients who were admitted to our center between January 2017 and January 2021, wereevaluated retrospectively from the medical records.Results: Three hundred-two naive HIV patients were enrolled in the study.
💡
Sonuç & Katkı:Positive syphilis antibody rate was found to be statistically higher in patients with substance abuse (p<0.01), CD4+ T lymphocytecounts were under 200 cell/mm³ (p=0.018) and viral load above 100.000 copies/mL (p<0.01).Conclusion: Among HIV-infected patients, those with MSM and substance abuse constitute the group at highest risk of syphilis.Therefore, syphilis must be screened and treated, especially at HIV diagnosis and high-risk behaviors.
🔬Tür:Araştırma Makalesi
📍Kapsam:2017 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Aim: Syphilis coinfection is common among human immune deficiency virus (HIV)/acquired immune deficiency syndrome (AIDS)diagnosed patients. We aimed to investigate the rates of syphilis coinfection, social-demographical features, viral and immunologicalproperties among naive HIV/AIDS patients.Methods: Socio-demographical data, CD4+ T lymphocyte counts, HIV viral load, syphilis antibody results and physical examinations atthe time of diagnosis of naive HIV infected patients who were admitted to our center between January 2017 and January 2021, wereevaluated retrospectively from the medical records.Results: Three hundred-two naive HIV patients were enrolled in the study. Positive syphilis antibody rate was detected as 21.5% and86.2% of those patients were male and also found 31.4% (p<0.01) in patients in which route of transmission was men sex with men(MSM). Positive syphilis antibody rate was found to be statistically higher in patients with substance abuse (p<0.01), CD4+ T lymphocytecounts were under 200 cell/mm³ (p=0.018) and viral load above 100.000 copies/mL (p<0.01).Conclusion: Among HIV-infected patients, those with MSM and substance abuse constitute the group at highest risk of syphilis.Therefore, syphilis must be screened and treated, especially at HIV diagnosis and high-risk behaviors.

🔖

Bu Makaleye Atıf Yap

OZDEMİR, H. O., TOSUN, S., BOZACİ, I. (2021). Risk Factors and Seroprevalence of Syphilis Among Naive HIV Patients: A Cross-Sectional Study From a Tertiary Center. Haseki Tıp Bülteni, Cilt: 59 - Sayı: 4, 313–318. https://ajindex.com/articles/347912

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Tudor ME, Al Aboud AM, Gossman WG. Syphilis. Last Updated March 22, 2021. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from: https://www.ncbi.nlm. nih.gov/books/NBK534780/. Accessed May 6, 2021
  2. Maan I, Lawrence DS, Tlhako N, et al. Using a dual antibody point-of-care test with visual and digital reads to diagnose syphilis among people living with HIV in Botswana. Int J STD AIDS 2021;32:453-61
  3. Kotsafti O, Paparizos V, Kourkounti S, Chatziioannou A, Nicolaidou E, Kapsimali V, Antoniou C. Early syphilis affects markers of HIV infection. Int J STD AIDS 2016;27:739-45
  4. Frunza-Stefan S, Acharya G, Kazlouskaya V, Vukasinov P, Chiou Y, Thet Z. Immune reconstitution inflammatory syndrome associated with secondary syphilis. Int J STD AIDS 2017;28:302-5
  5. TC.Sağlık Bakanlığı HIV-AIDS İstatistik Available from: https:// hsgm.saglik.gov.tr/tr/bulasici-hastaliklar/hiv-aids/hiv-aidsliste/hiv-aids-istatislik.html. Accessed May 6, 2021
  6. Oncul O, Emekdas G, Cavuslu S, Artuk C, Aksoy A. The sixteenyear trend of syphilis in Turkey: data from blood donors. Trop Doct 2008;38:181-2
  7. Akın L. Epidemiology of sexually transmitted infection: review. Turkiye Klinikleri J Med Sci 2006;26:655-65
  8. Köksal MO, Beka H, Evlice O, et al. Syphilis seroprevalence among HIV-infected males in Istanbul, Turkey. Rev Argent Microbiol 2020;52:266-71
  9. Karumudi UR, Augenbraun M. Syphilis and HIV: a dangerous duo. Expert Rev Anti Infect Ther 2005;3:825-31
  10. European AIDS Clinical Society (EACS) Guidelines. Version 10.1 - October 2020. Available from: https://www.eacsociety. org/guidelines/eacs-guidelines/eacs-guidelines.htmlAccessed May 6, 2021
  11. HIV infection: detection, counseling, and referral. Sexually transmitted diseases treatment guidelines CDC; 2021 Available from: https://www.cdc.gov/std/tg2015/hiv.htm. Accessed May 6, 2021
  12. Centers for Disease Control and Prevention (CDC). Revised surveillance case definition for HIV infection--United States, 2014. MMWR Recomm Rep 2014;63(RR-03):1-10
  13. French P, Gomberg M, Janier M, et al. IUSTI: 2008 European Guidelines on the Management of Syphilis. Int J STD AIDS 2009;20:300-9
  14. Salado-Rasmussen K. Syphilis and HIV co-infection. Epidemiology, treatment and molecular typing of Treponema pallidum. Dan Med J 2015;62:B5176
  15. TC. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. HIV/AIDS Tanı Tedavi Rehberi 2019. Available from: https://hsgm.saglik. gov.tr/depo/birimler/Bulasici-ha